Literature DB >> 30759018

Common Mechanisms Linking Chronic Obstructive Pulmonary Disease and Lung Cancer.

A McGarry Houghton1.   

Abstract

Chronic obstructive pulmonary disease (COPD) and lung cancer are linked diseases, with both the incidence of and risk of death from non-small cell lung cancer being increased by the presence of COPD. Despite numerous well-performed epidemiological studies having described this link over the past 30 years, the operative mechanisms remain elusive. One of the major obstacles to advancement in the field has been the lack of patient cohorts that have been phenotyped for both COPD and lung cancer. This review discusses several studies performed over the past few years highlighting the impact of COPD on the outcomes of patients with non-small cell lung cancer with respect to lung cancer screening, immune-based therapies, and lung cancer chemoprevention.

Entities:  

Keywords:  COPD; immunology; lung cancer

Mesh:

Year:  2018        PMID: 30759018      PMCID: PMC6322005          DOI: 10.1513/AnnalsATS.201808-537MG

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  35 in total

1.  Emphysema scores predict death from COPD and lung cancer.

Authors:  Javier J Zulueta; Juan P Wisnivesky; Claudia I Henschke; Rowena Yip; Ali O Farooqi; Dorothy I McCauley; Mildred Chen; Daniel M Libby; James P Smith; Mark W Pasmantier; David F Yankelevitz
Journal:  Chest       Date:  2011-10-20       Impact factor: 9.410

2.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.

Authors:  R D Hautamaki; D K Kobayashi; R M Senior; S D Shapiro
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

3.  Cancer statistics, 2014.

Authors:  Rebecca Siegel; Jiemin Ma; Zhaohui Zou; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-01-07       Impact factor: 508.702

4.  IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.

Authors:  Mark Ayers; Jared Lunceford; Michael Nebozhyn; Erin Murphy; Andrey Loboda; David R Kaufman; Andrew Albright; Jonathan D Cheng; S Peter Kang; Veena Shankaran; Sarina A Piha-Paul; Jennifer Yearley; Tanguy Y Seiwert; Antoni Ribas; Terrill K McClanahan
Journal:  J Clin Invest       Date:  2017-06-26       Impact factor: 14.808

5.  The prognostic landscape of genes and infiltrating immune cells across human cancers.

Authors:  Andrew J Gentles; Aaron M Newman; Chih Long Liu; Scott V Bratman; Weiguo Feng; Dongkyoon Kim; Viswam S Nair; Yue Xu; Amanda Khuong; Chuong D Hoang; Maximilian Diehn; Robert B West; Sylvia K Plevritis; Ash A Alizadeh
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

6.  Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.

Authors:  Naiyer A Rizvi; Matthew D Hellmann; Alexandra Snyder; Pia Kvistborg; Vladimir Makarov; Jonathan J Havel; William Lee; Jianda Yuan; Phillip Wong; Teresa S Ho; Martin L Miller; Natasha Rekhtman; Andre L Moreira; Fawzia Ibrahim; Cameron Bruggeman; Billel Gasmi; Roberta Zappasodi; Yuka Maeda; Chris Sander; Edward B Garon; Taha Merghoub; Jedd D Wolchok; Ton N Schumacher; Timothy A Chan
Journal:  Science       Date:  2015-03-12       Impact factor: 47.728

7.  Association of radiographic emphysema and airflow obstruction with lung cancer.

Authors:  David O Wilson; Joel L Weissfeld; Arzu Balkan; Jeffrey G Schragin; Carl R Fuhrman; Stephen N Fisher; Jonathan Wilson; Joseph K Leader; Jill M Siegfried; Steven D Shapiro; Frank C Sciurba
Journal:  Am J Respir Crit Care Med       Date:  2008-06-19       Impact factor: 21.405

8.  T helper 17 cells play a critical pathogenic role in lung cancer.

Authors:  Seon Hee Chang; Seyedeh Golsar Mirabolfathinejad; Harshadadevi Katta; Amber M Cumpian; Lei Gong; Mauricio S Caetano; Seyed Javad Moghaddam; Chen Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

9.  Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study.

Authors:  D M Skillrud; K P Offord; R D Miller
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391

10.  IL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice.

Authors:  Fernando M Botelho; Carla M T Bauer; Donna Finch; Jake K Nikota; Caleb C J Zavitz; Ashling Kelly; Kristen N Lambert; Sian Piper; Martyn L Foster; James J P Goldring; Jadwiga A Wedzicha; Jennifer Bassett; Jonathan Bramson; Yoichiro Iwakura; Matthew Sleeman; Roland Kolbeck; Anthony J Coyle; Alison A Humbles; Martin R Stämpfli
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

View more
  3 in total

1.  Coexistence of Emphysema With Non-small-cell Lung Cancer Predicts the Therapeutic Efficacy of Immune Checkpoint Inhibitors.

Authors:  Yusuke Takayama; Takashi Nakamura; Yuki Fukushiro; Shohei Mishima; Ken Masuda; Hiroyasu Shoda
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Prevalence of lung cancer in chronic obstructive pulmonary disease: A systematic review and meta-analysis.

Authors:  Guixiang Zhao; Xuanlin Li; Siyuan Lei; Hulei Zhao; Hailong Zhang; Jiansheng Li
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

3.  Reduced Chronic Toxicity and Carcinogenicity in A/J Mice in Response to Life-Time Exposure to Aerosol From a Heated Tobacco Product Compared With Cigarette Smoke.

Authors:  Ee Tsin Wong; Karsta Luettich; Subash Krishnan; Sin Kei Wong; Wei Ting Lim; Demetrius Yeo; Ansgar Büttner; Patrice Leroy; Grégory Vuillaume; Stéphanie Boué; Julia Hoeng; Patrick Vanscheeuwijck; Manuel C Peitsch
Journal:  Toxicol Sci       Date:  2020-11-01       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.